AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CRISM Therapeutics Corporation

Net Asset Value May 20, 2020

10465_rns_2020-05-20_0d4f9733-99cb-455b-8637-4800e1074713.html

Net Asset Value

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 4030N

Amur Minerals Corporation

20 May 2020

20 May 2020

AMUR MINERALS CORPORATION

(AIM: AMC)

Director Change

Amur Minerals Corporation ("Amur" or the "Company"), the nickel-copper sulphide mineral exploration and resource development company focused on the far east of Russia, announces that Mr. Ljupco ("Lou") Naumovski is stepping down as a Non-executive Director of the Company with immediate effect in order to concentrate on his other business interests.  Mr. Naumovski will continue to support the Company as an advisor to the Board.

Robert Schafer, Non-executive Chairman of Amur Minerals Corporation, commented:

"We thank Lou for the time, energy and input that he has provided to Amur.  His Russia-specific knowledge and experience is of great value to the Company and we look forward to continuing working with Lou in his capacity as an advisor to the Board."

Market Abuse Regulation (MAR) Disclosure

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

Company

Amur Minerals Corp.
Nomad and Broker

S.P. Angel Corporate Finance LLP
Public Relations

Blytheweigh
Robin Young CEO Richard Morrison

Soltan Tagiev
Megan Ray

Tim Blythe
+7 (4212) 75 56 15 +44 (0) 20 3470 0470 +44 (0) 20 7138 3203

For additional information on the Company, visit the Company's website, www.amurminerals.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

BOASFIFWUESSEFI

Talk to a Data Expert

Have a question? We'll get back to you promptly.